CydsaB de CV (FRA:M34) Total Liabilities: €940.3 Mil (As of Mar. 2026)


FRA:M34 Cydsa SAB de CV FRA:M34
69 GF Score
Price €1.11
GF Value €0.94
! 5 Warning Signs
View Full Analysis

What is CydsaB de CV Total Liabilities?

CydsaB de CV FRA:M34 -0.54% 69 Total Liabilities is €940.3 Mil as of Mar. 2026. GuruFocus rates FRA:M34 with a GF Score™ of 69/100 and a GF Value™ of €0.94. The stock has 5 warning signs investors should review.

CydsaB de CV's Total Liabilities for the quarter that ended in Mar. 2026 was €940.3 Mil.

CydsaB de CV's quarterly Total Liabilities increased from Sep. 2025 (€888.58 Mil) to Dec. 2025 (€920.32 Mil) and increased from Dec. 2025 (€920.32 Mil) to Mar. 2026 (€940.33 Mil).

CydsaB de CV's annual Total Liabilities increased from Dec. 2023 (€899.81 Mil) to Dec. 2024 (€911.06 Mil) and increased from Dec. 2024 (€911.06 Mil) to Dec. 2025 (€920.32 Mil).

CydsaB de CV Total Liabilities Historical Data

* Premium members only.

The historical data trend for CydsaB de CV's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CydsaB de CV Total Liabilities Chart

CydsaB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 842.03 917.22 899.81 911.06 920.32

CydsaB de CV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 887.26 866.35 888.58 920.32 940.33
FRA:M34
69GF Score
Cydsa SAB de CV FRA:M34
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CydsaB de CV Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CydsaB de CV's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=278.6+(600.789+4.363
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+32.537+4.032)
=920.3

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1525.283-604.962
=920.3

CydsaB de CV's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=285.624+(602.576+18.022
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+34.109+4.032)
=940.3

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1547.095-606.764
=940.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €940.3 Mil mean?
CydsaB de CV (FRA:M34) has a Total Liabilities of €940.3 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CydsaB de CV and its competitors.
Is CydsaB de CV's Total Liabilities too high?
CydsaB de CV's current Total Liabilities is €940.3 Mil. Overall, CydsaB de CV has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does CydsaB de CV's Total Liabilities compare to DOW?
CydsaB de CV's Total Liabilities of €940.3 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Chemicals company?
A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CydsaB de CV and its competitors. CydsaB de CV's current Total Liabilities is €940.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CydsaB de CV stock overvalued right now?
CydsaB de CV (FRA:M34) has a current Total Liabilities of €940.3 Mil. The stock's GF Value™ is €0.94, compared to a current price of €1.11 — trading 18.5% above its estimated fair value. The current Total Liabilities is €940.3 Mil. CydsaB de CV's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For CydsaB de CV (FRA:M34), the current Total Liabilities is €940.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CydsaB de CV (FRA:M34) Overvalued in 2026?

Based on GuruFocus' analysis, CydsaB de CV stock appears to be overvalued. The current stock price of €1.11 is trading 18.5% above its estimated GF Value™ of €0.94.

Key valuation signals for FRA:M34:

  • Total Liabilities: €940.3 Mil
  • GF Value™: €0.94 vs. price of €1.11 (18.5% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the FRA:M34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CydsaB de CV Business Description

Other Exchanges CYDSASAA:Mexico
Address Av. Ricardo Margain Zozaya No. 335, Tower 2, Floor 6, Col. Valle del Campestre, Garza Garcia, NL, MEX, 66265
Cydsa SAB de CV is engaged in production and sales of plastic pipes and fittings and irrigation systems, refrigerant gas, acrylic yarns, polyvinyl chloride resin, chlorine-caustic soda, and salt. The operating segments of the company are Chemical Products and Specialties, Refrigerant Gases and Energy Processing and Logistics. It generates maximum revenue from the Chemical Products and Specialties segment. Geographically, it derives a majority of revenue from Mexico and also has a presence in the United States and Canada; Central and South America and Europe.
69GF Score

Get the complete analysis for FRA:M34

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.11
Price
€0.94
GF Value